Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS

@article{Wu2011EfficacyAS,
  title={Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS},
  author={Ling-Yun Wu and Xiao Li and Jiying Su and Qi He and Xiaoying Zhang and Chunkang Chang and Quan Pu},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2011},
  volume={137},
  pages={1563-1569}
}
To evaluate the efficacy and toxicity of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as an induction chemotherapy for elderly patients with high-risk MDS or acute myeloid leukemia transformed from MDS (MDS–AML). Thirty-three untreated patients (21 high-risk MDS and 12 MDS–AML) were enrolled in this study. Each patient was administered with the CHG regimen comprised of low-dose cytarabine (25 mg/day, days 1–14) and homoharringtonine (1 mg/day, days 1–14) by… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

EVect of priming with granulocyte colony stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

  • B Löwenberg, W van Putten, M Theobald
  • N Engl J Med
  • 2003
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…